Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Census Delays Planned DDMAC Studies On Various Aspects Of DTC Advertising

Executive Summary

FDA's ability to conduct studies of direct-to-consumer advertising is being impacted by the 2010 census, slowing two pending FDA studies just as the agency is preparing to start three more

You may also be interested in...



FDA Advertising Studies Move Forward Along Several Broad Fronts

FDA Advertising Studies Move Forward Along Several Broad Fronts

FDA Advertising Studies Will Examine Website Formatting, Patient Testimonials, Outside Links

The agency will examine how various aspects of Internet-based ads affect consumer understanding of product safety and efficacy in four separate studies.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS052154

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel